Market Overview

UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition

Share:
Related AET
Goldman Adds Cigna To Conviction Buy List, Expects DoJ Announcement To Refocus Investors On Standalone Merits
JPMorgan Downgrades Humana Following Deal Reports
Cigna Is Health Latest Insurer To Warn On ObamaCare Costs (Investor's Business Daily)

In a report published Thursday, Jefferies analyst David Windley reiterated a Buy rating on Aetna (NYSE: AET), and raised the price target from $69.00 to $74.00.

In the report, Jefferies noted, “We are raising our EPS projections to reflect the Coventry acquisition by 5-10c more than accretion guidance of $0.45-0.90 in 2014-15. The company's diversified business, strong execution, modest exposure to Exchange risk, and low-to-mid teens EPS growth make AET our favorite MCO. At 9.5x 2014E EPS, AET is second cheapest in the group with the most attractive risk/reward profile. Raising our PT to $74.”

Aetna closed on Wednesday at $60.29.

Latest Ratings for AET

DateFirmActionFromTo
Jul 2016Wolfe ResearchDowngradesOutperformPeer Perform
Jun 2016BernsteinInitiates Coverage onOutperform
Apr 2016ClevelandInitiates Coverage onNeutral

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (AET)

View Comments and Join the Discussion!